FDA Inspection 1110897 — LabCorp Early Development Laboratories Limited.
The FDA completed an inspection of LabCorp Early Development Laboratories Limited. on September 27, 2019 in Harrogate. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 27, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Harrogate (United Kingdom)
Additional Details
Bioanalytical BA/BE